Granules India’s stock has dropped 13% amid a series of regulatory challenges from the USFDA. The agency's recent inspection of the Gagillapur facility resulted in six significant observations, leading to investor concerns and a sharp decline in share value. This blog delves into the details of the USFDA's findings, Granules India’s response, and the broader implications for the company and its investors. Stay tuned for a comprehensive analysis of this developing story.
Adani Wilmar's stock surged by 5% following a significant demerger announcement by its parent company, Adani Enterprises. This strategic move, which involves separating the food-FMCG business and investments in Adani Commodities LLP, aims to streamline operations and enhance growth potential. Explore how this change is expected to impact Adani Wilmar's financial performance and what it means for investors.